We are live on ! Find out more
RARE icon

Ultragenyx Pharmaceutical
RARE

236 hedge funds and large institutions have $3.87B invested in Ultragenyx Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 94 increasing their positions, 75 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 23

54% more capital invested

Capital invested by funds: $2.52B → $3.87B (+$1.36B)

25% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 75

8% more funds holding

Funds holding: 219 → 236 (+17)

0.1% less ownership

Funds ownership: 98.74% → 98.64% (-0.1%)

1% less call options, than puts

Call options by funds: $23.1M | Put options by funds: $23.4M

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
236
Holders Change
+17
Holders Change %
+7.76%
% of All Funds
3.44%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
44
Increased
94
Reduced
75
Closed
23
Calls
$23.1M
Puts
$23.4M
Net Calls
-$285K
Net Calls Change
-$1.62M

Top Buyers

1
Sands Capital Management
Sands Capital Management
Virginia
+$59.7M
2
RI
RTW Investments
New York
+$57.5M
3
SCM
Suvretta Capital Management
New York
+$56.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$55.8M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$36.2M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$44.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$23.8M
4
FLAM
First Light Asset Management
Minnesota
-$14.7M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$9.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
76
Pinnacle Associates
New York
$5.71M +$194 +5 +0%
PCM
77
Peregrine Capital Management
Minnesota
$5.7M -$797K -20,570 -15%
UBS AM
78
UBS AM
Illinois
$5.65M +$143K +3,685 +3%
Citigroup
79
Citigroup
New York
$5.28M +$773K +19,930 +22%
Mirae Asset Global Investments
80
Mirae Asset Global Investments
South Korea
$5.18M -$3.98M -102,613 -49%
Point72 Asset Management
81
Point72 Asset Management
Connecticut
$4.9M -$23.8M -613,962 -86%
SGA
82
Sector Gamma AS
Norway
$4.9M -$491K -12,676 -11%
California Public Employees Retirement System
83
California Public Employees Retirement System
California
$4.86M – – –
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
$4.81M +$312K +8,050 +9%
CAG
85
Crestwood Advisors Group
Massachusetts
$4.79M – – –
CCM
86
Cinctive Capital Management
New York
$4.69M +$3.8M +98,051 New
Amundi
87
Amundi
France
$4.59M -$1.28M -33,054 -26%
Man Group
88
Man Group
United Kingdom
$4.2M +$3.4M +87,811 New
Connor, Clark & Lunn Investment Management (CC&L)
89
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.13M -$3.71M -95,778 -53%
State Board of Administration of Florida Retirement System
90
State Board of Administration of Florida Retirement System
Florida
$4.09M +$42.1K +1,087 +1%
Balyasny Asset Management
91
Balyasny Asset Management
Illinois
$3.97M +$3.22M +82,933 New
BNP Paribas Asset Management
92
BNP Paribas Asset Management
France
$3.95M +$3.2M +82,619 New
California State Teachers Retirement System (CalSTRS)
93
California State Teachers Retirement System (CalSTRS)
California
$3.69M -$23.4K -603 -0.8%
New York State Common Retirement Fund
94
New York State Common Retirement Fund
New York
$3.48M +$763K +19,673 +37%
Legal & General Group
95
Legal & General Group
United Kingdom
$3.48M +$151K +3,899 +6%
Neuberger Berman Group
96
Neuberger Berman Group
New York
$3.34M -$2.45M -63,240 -48%
EAM
97
EFG Asset Management
Oregon
$3.27M +$409K +10,547 +18%
SEI Investments
98
SEI Investments
Pennsylvania
$3.13M +$381K +9,828 +18%
State of New Jersey Common Pension Fund D
99
State of New Jersey Common Pension Fund D
New Jersey
$3.11M -$127K -3,269 -5%
UBS Group
100
UBS Group
Switzerland
$2.77M +$443K +11,429 +25%
2 3
4
5 6

RARE Hedge Fund Activity: Q4 2023 in Review

236 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Ultragenyx Pharmaceutical (RARE) for Q4 2023, worth a combined $3.87B — up 54% from $2.52B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new RARE positions and 23 closed out — a net gain of 21 holders — while 94 added to existing stakes and 75 trimmed.

The largest buyer was Sands Capital Management, adding an estimated $59.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $44.6M.

  • 236 institutional investors held Ultragenyx Pharmaceutical (RARE) as of Q4 2023, up from 219 in Q3 2023.
  • Funds reported $3.87B of Ultragenyx Pharmaceutical stock for Q4 2023, up 54% quarter-over-quarter.
  • 44 funds opened new Ultragenyx Pharmaceutical positions in Q4 2023 and 23 closed out, a net change of +21 holders.
  • The largest Ultragenyx Pharmaceutical buyer in Q4 2023 was Sands Capital Management, an estimated $59.7M added.
  • The largest Ultragenyx Pharmaceutical seller in Q4 2023 was Avoro Capital Advisors, an estimated $44.6M sold.

Based on aggregated 13F filings for Q4 2023.